Alexopoulos, G. S., Meyers, B. S., Young, R. C.
et al (1997) ‘Vascular depression’ hypothesis. Archives of General Psychiatry, 54, 915–922.
Davies, S. J. C., Jackson, P. R., Potokar, J.
et al (2004) Treatment of anxiety and depressive disorders in patients with cardiovascular disease. BMJ, 328, 939–943.
Davous, P. (1998) CADASIL: a review with proposed diagnostic criteria. European Journal of Neurology, 5, 219–233.
Desmond, D. W., Moroney, J. T., Lynch, T.
et al (1999) The natural history of CADASIL: a pooled analysis of previously published cases. Stroke, 30, 1230–1233.
Dichgans, M., Mayer, M., Uttner, I.
et al (1998) The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Annals of Neurology, 44, 731–739.
Dichgans, M., Markus, H. S.
et al (2008) Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurology, 7, 310–318.
Faculty for the Psychiatry of Old Age (2006) Atypical Antipyschotics and Behavioural and Psychiatric Symptoms of Dementia: Prescribing Update for Old Age Psychiatrists. Royal College of Psychiatrists (http://www.rcpsych.ac.uk/PDF/BPSD.pdf).
Holtmannspotter, M., Peters, N., Opherk, C.
et al (2005) Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: a two year follow-up study. Stroke, 36, 2559–2565.
Joutel, A., Vahedi, K., Corpechot, C.
et al (1997) Strong clustering and stereotyped nature of notch3 mutations in CADASIL patients. Lancet, 350, 1511–1515.
Kalaria, R. N., Viitanen, M., Kalimo, H.
et al (2004) The pathogenesis of CADASIL: an update. Journal of Neurological Sciences, 226, 35–39.
Kennedy, G. J. & Marcus, P. (2005) Use of antidepressants in older patients with co-morbid medical conditions: guidance from studies of depression in somatic illness. Drugs and Aging, 22, 273–287.
Kessing, L. V. (2005) Severe brain pathology: underdiagnosed in psychiatric patients? (Invited comment). Acta Psychiatrica Scandinavica, 111, 396–397.
Keverne, J. S., Low, W. C., Ziabreva, I.
et al (2006) Cholinergic neuronal deficits in CADASIL. Stroke, 38, 188–191.
Kumar, P. & Clark, M. (2005) Clinical Medicine (6th edn). Elsevier.
Lagas, P. A. & Juvonen, V. (2001) Schizophrenia in a patient with cerebral autosomally dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL disease). Nordic Journal of Psychiatry, 55, 41–42.
Leyhe, T., Wiendl, H., Buchkremer, G.
et al (2005) CADASIL: underdiagnosed in psychiatric patients?
Acta Psychiatrica Scandinavica, 111, 392–396.
Markus, H. S., Martin, R. J., Simpson, M. A.
et al (2002) Diagnostic strategies in CADASIL. Neurology, 59, 1134–1138.
Mesulam, M., Siddique, T. & Cohen, B. (2003) Cholinergic denervation in a pure multi-infarct state. Neurology, 60, 1183–1185.
National Collaborating Centre for Mental Health (2006) Dementia: Supporting People with Dementia and Their Carers in Health and Social Care (NICE Clinical Guideline 42). National Institute for Health and Clinical Excellence.
Opherk, C., Peters, N., Holtmannspotter, M.
et al (2006), Heritability of MRI lesion volume in CADASIL: evidence for genetic modifiers. Stroke, 37, 2684–2689.
O'Sullivan, M., Jarosz, J. M., Martin, R. J.
et al (2001) MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology, 56, 628–634.
Pantoni, L., Pescini, F., Inzitari, D.
et al (2005) Postpartum psychiatric disturbances as an unrecognised onset of CADASIL. Acta Psychiatrica Scandinavica, 112, 241.
Razvi, S. S. M., Davidson, R., Bone, I.
et al (2005) The prevalence of CADASIL in the West of Scotland. Journal of Neurology, Neurosurgery and Psychiatry, 76, 739–741.
Schon, F., Martin, R. J., Prevett, M.
et al (2003) ‘CADASIL coma’: an underdiagnosed acute encephalopathy. Journal of Neurology, Neurosurgery and Psychiatry, 74, 249–252.
Singhal, S., Bevan, S., Barrick, T.
et al (2004) The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain, 127, 2031–2038.
Singhal, S., Rich, P. & Markus, H. S. (2005) The spatial distribution of MR imaging abnormalities in CADASIL and their relationship to age and clinical features. American Journal of Neuroradiology, 26, 2481–2487.
Spalletta, G., Bossa, P., Ciaramella, A.
et al (2006) The aetiology of post-stroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Molecular Psychiatry, 11, 984–991.
Taylor, D., Paton, C. & Kerwin, R. (2007) Maudsley Prescribing Guidelines (9th edn). Informa Healthcare.
Verin, M., Rolland, Y., Landgraf, F.
et al (1995) New phenotype of the cerebral autosomal dominant arteriopathy mapped to chromosome 19: migraine as the prominent clinical feature. Journal of Neurology, Neurosurgery and Psychiatry, 59, 579–585.
Viswanathan, A., Guichard, J. P., Gschwendtner, A.
et al (2006) Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. Brain, 129, 2375–2383.
Waldemar, G., Dubois, B., Emre, M.
et al (2007) Recommendations for the diagnosis and management of Alzheimer's and other disorders associated with dementia: EFNS (European Federation of Neurological Science) guideline. European Journal of Neurology, 14, e1–e26.